Erratum to: Rapid immunohistochemistry based on alternating current electric field for intraoperative diagnosis of brain tumors

M. Tanino,T. Sasajima,H. Nanjo,Shiori Akesaka,Masami Kagaya,Taichi Kimura,Yusuke Ishida,M. Oda,Masataka Takahashi,T. Sugawara,T. Yoshioka,H. Nishihara,Y. Akagami,A. Goto,Y. Minamiya

DOI: https://doi.org/10.1007/s10014-014-0194-0

Brain Tumor Pathology

Abstract:

What problem does this paper attempt to address?

Prevalence, sex differences, and implications of pulmonary hypertension in patients with apical hypertrophic cardiomyopathy

Vidhu Anand,Megan K. Covington,Ushasi Saraswati,Christopher G. Scott,Alexander T. Lee,Robert P. Frantz,Nandan S. Anavekar,Jeffrey B. Geske,Adelaide M. Arruda-Olson,Kyle W. Klarich

DOI: https://doi.org/10.3389/fcvm.2023.1288747

IF: 3.6

2024-01-12

Frontiers in Cardiovascular Medicine

Abstract:Introduction: Apical hypertrophic cardiomyopathy (ApHCM) is a subtype of hypertrophic cardiomyopathy (HCM) that affects up to 25% of Asian patients and is not as well understood in non-Asian patients. Although ApHCM has been considered a more "benign" variant, it is associated with increased risk of atrial and ventricular arrhythmias, apical thrombi, stroke, and progressive heart failure. The occurrence of pulmonary hypertension (PH) in ApHCM, due to elevated pressures on the left side of the heart, has been documented. However, the exact prevalence of PH in ApHCM and sex differences remain uncertain. Methods: We sought to evaluate the prevalence, risk associations, and sex differences in elevated pulmonary pressures in the largest cohort of patients with ApHCM at a single tertiary center. A total of 542 patients diagnosed with ApHCM were identified using ICD codes and clinical notes searches, confirmed by cross-referencing with cardiac MRI reports extracted through Natural Language Processing and through manual evaluation of patient charts and imaging records. Results: In 414 patients, echocardiogram measurements of pulmonary artery systolic pressure (PASP) were obtained at the time of diagnosis. The mean age was 59.4 ± 16.6 years, with 181 (44%) being females. The mean PASP was 38 ± 12 mmHg in females vs. 33 ± 9 mmHg in males ( p 36 mmHg was present in 140/414 (34%) patients, with a predominance in females [79/181 (44%)] vs. males [61/233 (26%), p 36 mmHg) in multivariable modeling. PH, when present, was independently associated with mortality [hazard ratio 1.63, 95% CI (1.05–2.53), p = 0.028] and symptoms [odds ratio 2.28 (1.40, 3.71), p < 0.001]. Conclusion: PH was present in 34% of patients with ApHCM at diagnosis, with female sex predominance. PH in ApHCM was associated with symptoms and increased mortality.

cardiac & cardiovascular systems
Apical Ischemia Is a Universal Feature of Apical Hypertrophic Cardiomyopathy

Rebecca K. HughesJoão B. AugustoKristopher KnottRhodri DaviesHunain ShiwaniAndreas SeraphimJames W. MalcolmsonShafik KhouryGeorge JoySaidi MohiddinLuis R. LopesWilliam J. McKennaPeter KellmanHui XueMaite TomeSanjay SharmaGabriella CapturJames C. MoonInstitute of Cardiovascular Science (R.K.H.,J.B.A.,K.K.,R.D.,H.S.,A.S.,G.J.,L.R.L.,W.J.M.,G.C.,J.C.M.),University College London,United Kingdom.MRC Unit for Lifelong Health and Ageing (R.D.,G.C.),University College London,United Kingdom.Barts Heart Centre,The Cardiovascular Magnetic Resonance Imaging Unit and The Inherited Cardiovascular Diseases Unit,St Bartholomew's Hospital,West Smithfield,London,United Kingdom (R.K.H.,J.B.A.,K.K.,R.D.,H.S.,A.S.,J.W.M.,G.J.,S.M.,L.R.L.,J.C.M.).Cardiology Department,Hospital Professor Doutor Fernando Fonseca,Amadora,Portugal (J.B.A.).William Harvey Institute,Queen Mary University of London,United Kingdom (J.W.M.,S.M.,M.T.,S.S.).Cardiovascular Clinical and Academic Group,Molecular and Clinical Sciences Institute,St. George's University of London,United Kingdom (S.K.)Instituto de Investigación Biomédica de A Coruña,Spain (W.J.M.).National Heart,Lung,and Blood Institute,National Institutes of Health,Department of Human and Health Services,Bethesda,MD (P.K.,H.X.).Department of Cardiology,Inherited Heart Muscle Conditions Clinic,Royal Free Hospital,NHS Trust,United Kingdom (G.C.).

DOI: https://doi.org/10.1161/CIRCIMAGING.122.014907

2023-03-22

Abstract:Circulation: Cardiovascular Imaging, Volume 16, Issue 3, Page e014907, March 1, 2023. Background:Apical hypertrophic cardiomyopathy (ApHCM) accounts for ≈10% of hypertrophic cardiomyopathy cases and is characterized by apical hypertrophy, apical cavity obliteration, and tall ECG R waves with ischemic-looking deep T-wave inversion. These may be present even with <15 mm apical hypertrophy (relative ApHCM). Microvascular dysfunction is well described in hypertrophic cardiomyopathy. We hypothesized that apical perfusion defects would be common in ApHCM.Methods:A 2-center study using cardiovascular magnetic resonance short- and long-axis quantitative adenosine vasodilator stress perfusion mapping. One hundred patients with ApHCM (68 overt hypertrophy [≥15 mm] and 32 relative ApHCM) were compared with 50 patients with asymmetrical septal hypertrophy hypertrophic cardiomyopathy and 40 healthy volunteer controls. Perfusion was assessed visually and quantitatively as myocardial blood flow and myocardial perfusion reserve.Results:Apical perfusion defects were present in all overt ApHCM patients (100%), all relative ApHCM patients (100%), 36% of asymmetrical septal hypertrophy hypertrophic cardiomyopathy, and 0% of healthy volunteers (P<0.001). In 10% of patients with ApHCM, perfusion defects were sufficiently apical that conventional short-axis views missed them. In 29%, stress myocardial blood flow fell below rest values. Stress myocardial blood flow was most impaired subendocardially, with greater hypertrophy or scar, and with apical aneurysms. Impaired apical myocardial blood flow was most strongly predicted by thicker apical segments (β-coefficient, −0.031 mL/g per min [CI, −0.06 to −0.01];P=0.013), higher ejection fraction (−0.025 mL/g per min [CI, −0.04 to −0.01];P<0.005), and ECG maximum R-wave height (−0.023 mL/g per min [CI, −0.04 to −0.01];P<0.005).Conclusions:Apical perfusion defects are universally present in ApHCM at all stages. Its ubiquitous presence along with characteristic ECG suggests ischemia may play a disease-defining role in ApHCM.

radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems
Electromechanical Relationship in Hypertrophic Cardiomyopathy

Xiaoping Lin,Hsin-Yueh Liang,Aurelio Pinheiro,Veronica Dimaano,Lars Sorensen,Miguel Aon,Larisa G. Tereshchenko,Yihan Chen,Meixiang Xiang,Theodore P. Abraham,M. Roselle Abraham

DOI: https://doi.org/10.1007/s12265-013-9481-0

2013-01-01

Journal of Cardiovascular Translational Research

Abstract:We examined whether there is a relationship between repolarization abnormalities on electrocardiography (EKG) and deformation abnormalities by echocardiography. Analysis of baseline EKGs and mechanical (echo-based deformation) changes was performed in 128 patients with a clinical diagnosis of hypertrophic cardiomyopathy (HCM). Patients with left ventricular hypertrophy (LVH) or repolarization abnormalities had higher septal thickness when compared to patients with normal EKG. Patients with EKG evidence of LVH or QT c prolongation had lower systolic velocity, systolic strain, systolic strain rate, late diastolic velocity, and late diastolic strain rate than patients with a normal EKG. Patients with strain pattern or ST depression/T-wave inversion had lower systolic velocity, systolic strain, systolic strain rate, early diastolic velocity, and late diastolic velocity when compared to patients with normal EKGs. LVH and repolarization abnormalities on surface EKG are markers of impaired systolic and diastolic mechanics in HCM.
Determination of 1,4-Dioxane in Drinking Water by Gas Chromatography/Mass Spectrometry (GC/MS) with Selected Ion Monitoring (SIM)

M. Belmont,D. Steiniger,Eric Phillips,S. Guazzotti,A. Semyonov

Abstract:Introduction 1,4-Dioxane is used mainly as a stabilizer for 1,1,1-trichloroethane for transport in aluminum containers. It is an irritant to eyes and respiratory system and suspected of causing damage to nervous system, liver, and kidneys.1 In 2008, testing sponsored by the U.S. Organic Consumers Association found dioxane in almost half of tested organic personal-care products.1 Of the total 1.163 million pounds of 1,4-dioxane released into the U.S. environment in 1992, as reported to the Toxics Release Inventory, 680 thousand pounds (58.5%) were released into the atmosphere, 450 thousand pounds (38.7%) were released into surface waters, and 33 hundred pounds (2.8%) were released onto the land (TRI92 1994).2 In 2005, the New Hampshire Department of Environmental Services Waste Management Division started enforcement of an Ambient Groundwater Quality Standard reporting limit of 3 μg/L and trending towards a detection limit of 0.25 μg/L. 1,4-Dioxane has been detected in drinking water in the U.S. at a concentration of 1 μg/L. This application highlights the use of SIM/Full Scan to identify unknowns with a NIST library, while producing accurate results that meet EPA Method 522 requirements.
Interventricular Septal Involvement Is Associated with More Impaired Ventricular Function and Mechanics in Apical Hypertrophic Cardiomyopathy

Christos G. Mihos,Tarec K. Elajami,Deepika Misra,Pranav Venkataraman,Nicholas Gosdenovich,Rafle Fernandez

DOI: https://doi.org/10.3390/jcdd11030074

2024-02-21

Journal of Cardiovascular Development and Disease

Abstract:Background: The interventricular septum has an important role in bi-ventricular performance. We hypothesized that septal involvement in apical hypertrophic cardiomyopathy (ApHCM-Mixed) adversely impacts ventricular structure and function when compared with isolated apical hypertrophy (ApHCM-Pure). Methods: A total of 72 patients (ApHCM-Mixed = 36, ApHCM-Pure = 36) with serial 2D and speckle-tracking echocardiographic analyses were identified. Ventricular function and mechanics were characterized by left (LV) and right (RV) ventricular global longitudinal strain (GLS), RV free wall strain, and LV myocardial work indices, and clinical events were adjudicated. Results: Clinical characteristics were similar between groups (mean age, 66 ± 15 years; 49% female; LV ejection fraction, 68 ± 11%). The ApHCM-Mixed group had larger LV mass indexes (141 ± 39 vs. 111 ± 30 g/m2, p < 0.001), worse LV (−9.6 ± 3.1 vs. −14.4 ± 3.4%, p < 0.001) and RV GLS (−14.3 ± 6.7 vs. −19.2 ± 5.2%, p = 0.001), impaired RV free wall strain (−18.5 ± 7.4 vs. −22.4 ± 6.3%, p = 0.02), and lower LV myocardial work indices including global work index (938 ± 306 vs. 1272 ± 339 mmHg%, p < 0.001), when compared with the ApHCM-Pure group. At a mean follow-up of 3.9 years, these differences all persisted. Five deaths were observed, all occurring in the ApHCM-Mixed group (14% vs. 0, p = 0.05), and with four being cardiac-related. This subgroup had a mean LV ejection fraction of 63%, LV GLS of −8.7%, an LV global work index of 875 mmHg%, and RV free wall strain of −15.9%, indicating significant subclinical bi-ventricular dysfunction. Conclusions: ApHCM-Mixed represents a distinct morphology in hypertrophic cardiomyopathy associated with more impaired ventricular function and mechanics when compared with ApHCM-Pure.

cardiac & cardiovascular systems
Clinical Characteristics and Outcomes in Patients With Apical and Nonapical Hypertrophic Cardiomyopathy

Qin-Fen Chen,Jiahao Zou,Christos S Katsouras,Shenban You,Jian Zhou,Hang-Bin Ge,Chenyang Liu,Xi Zhou,Chao Ni,Yangdi Peng,Chenlv Hong,Wei-Hong Lin,Xiao-Dong Zhou

DOI: https://doi.org/10.1161/JAHA.124.036663

2024-09-18

Abstract:Background: Apical hypertrophic cardiomyopathy (ApHCM) is a variant of hypertrophic cardiomyopathy, with distinct clinical characteristics and outcomes. We aimed to clarify the natural history of patients with ApHCM and identify the risk of end-stage heart failure incidence. Methods and results: This retrospective study was conducted on patients with hypertrophic cardiomyopathy in China between January 2009 and February 2024. Patients were stratified into ApHCM and non-ApHCM groups. The primary outcome was a composite of major adverse cardiovascular events, including all-cause deaths, heart failure hospitalization, sudden cardiac death, and ventricular tachycardia. The secondary outcome was the incidence of end-stage heart failure, defined as left ventricular ejection fraction <50%. Kaplan-Meier and univariable and multivariable Cox proportional analyses were applied. Adjustment variables were included for important baseline characteristics, comorbidities, and medication use. Of 5653 patients enrolled with hypertrophic cardiomyopathy, 584 (10.3%) had ApHCM and 5069 (89.7%) had non-ApHCM. During the median follow-up period of 4.6 years (1.6-8.0 years), major adverse cardiovascular events occurred in 32.2% (n=1808), with a lower incidence in patients with ApHCM than non-ApHCM (20.4% versus 33.3%, P<0.001). Non-ApHCM was an independent predictor of major adverse cardiovascular events (hazard ratio [HR], 1.65 [95% CI, 1.36-1.99]; P<0.001). In the serial cohort, patients with ApHCM exhibited a lower incidence of end-stage heart failure than those with non-ApHCM (12.4% versus 2.7%, P<0.001). Non-ApHCM was associated with a higher risk of end-stage heart failure development (HR, 2.31 [95% CI, 1.28-4.15]; P<0.001). In subgroup and sensitivity analysis, the results were consistent for our main and secondary outcomes. Conclusions: ApHCM is relatively common in hypertrophic cardiomyopathy and shows lower rates of all-cause mortality and heart failure hospitalizations than non-ApHCM.
Clinical Course and Treatment of Patients With Apical Aneurysms Due to Hypertrophic Cardiomyopathy

Mark V Sherrid,Daniele Massera,Samuel Bernard,Nidhi Tripathi,Yash Patel,Vivek Modi,Leon Axel,Soheila Talebi,Muhamed Saric,Elizabeth Adlestein,Isabel Castro Alvarez,Maria C Reuter,Woon Y Wu,Yuhe Xia,Brian B Ghoshhajra,Danita Y Sanborn,Michael A Fifer,Daniel G Swistel,Bette Kim

DOI: https://doi.org/10.1016/j.jacadv.2024.101195

2024-08-27

Abstract:Background: There is controversy about risk of malignant arrhythmias and stroke in patients with apical aneurysms in hypertrophic cardiomyopathy (HCM). Objectives: The aim of this study was to estimate the associations of aneurysm size and major HCM risk factors with the incidence of lethal and potentially lethal arrhythmias and to estimate incidence of unexplained stroke. Methods: In 108 patients (age 57.4 ± 13.5 years, 37% female) from 3 HCM centers, we assessed American Heart Association/American College of Cardiology guidelines risk factors and initial aneurysm size by echocardiography and cardiac magnetic resonance imaging and assessed outcomes after median 5.9 (IQR: 3.7-10.0) years. Results: Implantable cardioverter defibrillator discharges or sudden cardiac death (SCD) occurred in 21 (19.4%) patients. Of patients with a risk factor, 55% subsequently had ventricular tachycardia (VT), ventricular fibrillation (VF), or SCD at follow-up, compared with 10% in those who did not (P < 0.001). The upper tercile of size had a 5-year cumulative risk of 35%, while the lower tercile had 5-year risk of 6% (P = 0.0046). In those with the smallest aneurysms <2 cm2 and also without risk factors VT, VF, or SCD occurred in only 2.5%. Clinical atrial fibrillation (AF) was prevalent, occurring in 49 (45%). Stroke was commonly associated with AF. Stroke without conventional cause had an incidence of 0.5%/year. Surgery in 19% was effective in reducing symptoms. VT ablation and surgery were moderately effective in preventing recurrent VT. Conclusions: Risk factors and aneurysm size were associated with subsequent VT, VF, or SCD. Patients with aneurysms in the lowest tercile of size have a low cumulative 5-year risk. Clinical AF occurred frequently. Stroke prevalence in absence of known stroke etiologies is uncommon and comparable to risk of severe bleeding.
[The echocardiographic diagnostic characteristics and follow-up of apical hypertrophic cardiomyopathy.].

Cheng-Jian Yang,Xin-He Ye,Xin Xu,Chun-Yuan You,Zhi-Hong Li,Da-Yi Hu

DOI: https://doi.org/10.3760/cma.j.issn.0578-1426.2010.02.010

2010-01-01

Abstract:OBJECTIVE:To evaluate the echocardiographic features of apical hypertrophic cardiomyopathy (ApHCM). METHODS:Twenty-seven patients with ApHCM including 21 men and 6 women, average age (42.7 +/- 5.1) years old were followed up from 1995 to 2008 to investigate the clinical, electrocardiographic and echocardiographic features. RESULTS:The major features of ECG were increased R amplitude (V(4) > V(5) > V(3)) and inverteted T wave (especially in V(3-5) leads and the voltage of the inverteted T waves may be up to >/= 10 mm). The major feature of echocardiography was the thickening of left ventricular apical wall to 15 - 37 (18.0 +/- 3.3) mm. The final follow up showed that the mean thickness of the apical wall was (19.7 +/- 3.7) mm. The ratio of the thickness of left ventricular apical wall to posterior wall before and after the follow up was 1.7 +/- 0.3 and 1.9 +/- 0.9 respectively, with significant statistical difference (P < 0.05). There was no difference in the left ventricular end-diastolic dimension and left ventricular ejection fraction. The main cardiovascular events were atrial fibrillation (16 cases), heart failure of NYHA III-IV class (3 cases), anterior wall myocardial infarction (1 case) and sudden death (1 case). CONCLUSIONS:The final diagnosis of ApHCM depends on the characteristic inverteted T wave in ECG and apical hypertrophy in echocardiography. The prognosis of ApHCM is rather good for its progression is relatively slow.
ASSA14-04-03 the Clinical Characteristics and Coronary Angiography Features of Patients with Apical Hypertrophic Cardiomyopathy

Liu Liwen,Du Zhankui,Wang Ya,Deng Jie,Shi Yana,Wang Xiaozeng,Han Yaling

DOI: https://doi.org/10.1136/heartjnl-2014-307109.69

IF: 5.7

2014-01-01

Heart

Abstract:Objective To analyse the clinical characteristics and coronary angiography features of patients with Apical Hypertrophic Cardiomyopathy (AHCM). Methods The baseline features, clinical characteristics and coronary angiography features were retrospectively analysed. Results 25.9% of all the Hypertrophic Cardiomyopathy (HCM) patients were diagnosed with AHCM patients (99 cases vs 382 cases). The mean age of males were younger than famales onset (52.0 ± 11.5 years vs 58.4 ± 10.5 years, p = 0.009). The major clinical characteristics were chest pain, dyspnea, angina and palpitation with 74.7%, 54.5%, 50.5% and 28.3% respectively (74, 54, 50 and 28 cases). Complications were hypertention, diabetes mellitus and hyperlipemia with 35.4%,12.1% and 4.0% respectively (35, 12 and 4 cases). 12-lead electrocardiogram (ECG) revealed sinus rhythm and left ventricular hypertrophy voltage on 72 patients (72.7%), and the gaint negative T waves were presented on 80 patients (80.8%) (maximum depth 2.4 mv). On echocardiography, mean apical wall thickness, interventricular septum thickness and left ventricular outflow tract gradient were 19 ± 8 mm, 16 ± 5 mm and 40 ± 49 mmHg respectively. Left ventricular angiography revealed left ventricular apex thickening in different degrees (maximum thickness 40 mm). A majority of patients (98.0%) revealed the “Spades” except for 2 cases described as similar “Spades”and “Ballet foot” respectively. Conclusions The AHCM, with a higher morbidity, generally have a benign prognosis. Left ventricular angiography should be performed when [1] electrocardiography and echocardiography are failed to diagnose.
Presence of Apical Aneurysm and Its Impact on Left Ventricular Mechanics and Mechano‐Energetic Coupling in Patients With Apical Hypertrophic Cardiomyopathy

Christos G. Mihos,Sarah A. Guigui,Sofia A. Horvath,Pranav Venkataraman,Rafle Fernandez,Tarec K. Elajami

DOI: https://doi.org/10.1111/echo.15938

2024-10-27

Echocardiography

Abstract:Central Figure Caption. Global longitudinal strain (left) and myocardial work index (right) showing markedly impaired mechanics of the apex, apical dyskinesis and systolic lengthening, and severely decreased mid‐ventricular and apical myocardial work. Background Left ventricular (LV) apical aneurysms (ApAn+) occur in 10%–15% of apical hypertrophic cardiomyopathy (ApHCM) patients and confer considerable morbidity. We hypothesized that ApAn+ adversely impact ventricular mechanics and mechano‐energetic coupling in ApHCM. Methods Ninety‐eight ApHCM patients were identified, of which nine (9%) had ApAn+ and were compared with 89 (91%) who did not (ApAn−). 2D speckle‐tracking echocardiography assessed ventricular mechanics using LV global longitudinal strain (GLS) and torsion, and mechano‐energetic coupling as myocardial work indices. Clinical events over follow‐up were adjudicated. Results Mean age was 64 ± 15 years, 46% were female, and 3% had an HCM family history, with similar clinical risk factors between groups. Of the nine ApAn+ patients, there were six small (<2 cm) and three moderate‐sized (2‐4 cm) aneurysms. There was no difference in LV ejection fraction (65 ± 15 vs. 67 ± 11%, p = 0.51) or GLS (−9.6 ± 3.3 vs. −11.9 ± 3.9%, p = 0.09) between ApAn+ versus ApAn−. ApAn+ patients had greater myocardial global wasted work (347 ± 112 vs. 221 ± 165 mmHg%, p = 0.03) and lower global work efficiency (GWE, 75 ± 5 vs. 82 ± 8%, p = 0.006). LV GLS (β = −0.67, p < 0.001), ApAn+ (β = −0.15, p = 0.04), and twist rate (β = −0.14, p = 0.04) were independently associated with GWE. At 3.9‐year follow‐up, cardiovascular mortality (4%) and heart failure hospitalization (14%) events were similar between groups. Conclusion ApHCM patients with ApAn+ are characterized by more impaired LV mechano‐energetic coupling when compared with ApAn−. ApAn+ is independently associated with worse GWE.

cardiac & cardiovascular systems
Value of Multidetector Computed Tomography in Patients With Chest Pain and Suspected Apical Hypertrophic Cardiomyopathy

Abstract:The diagnosis of apical hypertrophic cardiomyopathy (AHC) is based on the demonstration of myocardial hypertrophy in the apical region of the left ventricle, usually by echocardiogram. However, the ultrasound diagnosis is not always possible, unless a contrast agent is used to render the ventricular chamber opaque and thus obtain a typical “ace of spades” configuration of the left ventricle. On the other hand, in patients with AHC, coronary disease is frequently suspected. Given the limitations of ultrasound and other non-invasive tests for the detection of ischaemia in these cases, multidetector computed tomography (CT), which makes it possible both to study the ventricular myocardium and the coronary arterial tree, is seen as a particularly interesting tool for the integral assessment of these patients. We present 3 patients with AHC who had a heart CT in our centre to rule out coronary disease. The first is a male who had previously had an echocardiogram for screening for hypertrophic cardiomyopathy (as he had a child diagnosed with this condition) and he was reported to be normal. Three years before he had consulted due to chest pain compatible with stress angina, but the echocardiogram test was negative. On this occasion the patient consulted due to progression of his angina. The echocardiogram showed a sinus rhythm, incomplete right bundle block and negative T waves of high amplitude in V4V5 (Figure 1). A cardiac CT was indicated to rule out coronary disease. There was no significant coronary stenosis. Left ventriculography during cardiac CT showed a localized thickening of the apical segments of the left ventricular myocardium (Figure 1), which gave rise to a diagnosis of AHC. The second case is that of a 67-year-old woman, with a previous hospitalization due to chest pain. During this prior admittance her ECG showed a low amplitude T wave inversion, the echocardiogram did not show any significant alterations and a myocardial perfusion gamma scan ruled out ischaemia. In this case the patient consulted due to persistence of chest pain. The ECG showed a sinus rhythm, with criteria of left ventricle hypertrophy, T wave inversion in a precordial series of an amplitude >0.5 mV in V4-V5. A new echocardiogram was performed in which, suspecting AHC, contrast was given and the “ace of spades” image compatible with AHC was seen. To rule out coronary disease a non-invasive coronary angiography was performed with cardiac CT, which excluded significant arterial stenosis and confirmed thickening of the myocardium in an exclusively apical location compatible with AHC. The third case was a 35-year-old male who was admitted with epigastric pain that irradiated upwards. The patient had previously been diagnosed with hypertrophic cardiomyopathy. In the echocardiogram it is possible to see a descent of ST of 2 mm in V3-V5 and negative T waves in DIII, aVF, and V3-V6. A cardiac US was performed and as AHC was suspected contrast was administered for confirmation. To rule out coronary disease, a nonLETTERS TO THE EDITOR

Medicine
Non-invasive assessment of left ventricular hemodynamic forces in hypertrophic cardiomyopathy

G Panichella,A Del Franco,A Milazzo,C Zocchi,M Garofalo,A I Fanizzi,M Ragagnin,M Pieroni,M Zampieri,R H Chan,G Pedrizzetti,M Emdin,I Olivotto

DOI: https://doi.org/10.1093/eurheartj/ehae666.1977

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Background Hemodynamic force (HDF) analysis allows non-invasive measurement of intraventricular pressure gradients, portraying cyclic spatial-temporal interaction between blood and tissues. Impaired HDFs have been implicated in early detecting of adverse cardiac remodelling and treatment response in various cardiovascular disorders, providing insights into cardiac physiology not offered by traditional cardiovascular imaging (1). Mainly explored in heart failure, HDF analysis has not been previously applied to hypertrophic cardiomyopathy (HCM). Purpose To investigate differences in systo-diastolic function in HCM patients compared to healthy controls using HDF analysis. Methods Forty patients with HCM diagnosis (20 obstructive and 20 non-obstructive) were retrospectively evaluated in comparison with 22 healthy controls. Left ventricular (LV) HDFs were derived from routine transthoracic apical 4-, 2- and 3-chamber views using a dedicated software. Apical-basal HDF curves were generated, where positive deflections represent forces directed from the LV apex to the base, whilst negative ones are directed toward the apex. Amplitude and timing parameters were derived, the latter indexed to total cardiac cycle duration. Results Table 1 shows the demographic, clinical and echocardiographic characteristics of HCM compared to controls. Patients with HCM were older, had a slower heart rate due to treatment with beta-blockers, and showed hypercontractility, as expressed by higher LV ejection fraction. Compared to controls, HCM patients showed reduced LV longitudinal force, i.e. the force during the whole cardiac cycle (4.17% [2.36-5.52] vs. 6.01% [4.73-7.78], p=0.002), shorter time interval to systolic peak (0.15 [0.12-0.16] vs. 0.19 [0.17-0.20], p <0.001), and shorter duration of LV impulse (0.29 [0.27-0.32] vs. 0.34 [0.32-0.37], p <0.001) (Figure 1). However, no differences in terms of systolic force peak (p=0.283) or LV impulse intensity (p=0.689) were detected. During the transition between systole and diastole, LV suction (i.e. the interval including late systolic deceleration and early diastolic suction) was significantly longer (0.26 [0.22-0.29] vs. 0.23 [0.21-0.25], p=0.023) but less pronounced (6.30% [4.56-8.44] vs. 8.72% [6.71-12.59], p=0.005), likely reflecting a relaxation impairment from the very beginning of diastole. Such impairment was maintained during early diastolic filling, where the amplitude of the positive deceleration flow force was severely reduced in HCM compared to controls (2.98% [1.98-4.58] vs. 7.11% [4.55-8.72], p <0.001). Conclusions HDF analysis in HCM patients revealed unique systolic and diastolic changes reflecting faster LV contraction during systole and slower and weaker LV forces during diastole. This analysis deepens our understanding of HCM mechanic abnormalities and may help assess response to innovative treatment options.

cardiac & cardiovascular systems
P1594 Relationship between left ventricular morphology and systolic performance and coronary microcirculatory dysfunction in hypertrophic cardiomyopathy

S Aguiar Rosa,L Branco,A Galrinho,A Fiarresga,L Lopes,M Celas,F Silva,A F Carvalho,M Mota Carmo,R Cruz Ferreira

DOI: https://doi.org/10.1093/ehjci/jez319.1012

2020-01-01

Abstract:Abstract Background Myocardial ischemia constitutes one of the most important pathophysiological features in hypertrophic cardiomyopathy (HCM). Chronic and recurrent myocardial ischemia leads to fibrosis, which may culminate in myocardial dysfunction. Objective To analyse the relationship between left ventricular (LV) morphology and systolic performance and coronary microcirculatory dysfunction in HCM. Methods The present study prospectively included HCM patients (P) who underwent transthoracic echocardiography. Left ventricular (LV) function was evaluated by ejection fraction (LVEF), global longitudinal strain (GLS) and tissue Doppler septal and lateral s’. The evaluation of coronary flow velocity reserve (CFVR) was performed in apical three chambers view for the left anterior descending (LAD) artery and in an apical three chambers view for the posterior descending (PD) artery. Diastolic coronary flow velocity was measured in basal conditions and in hyperemia, induced by adenosine perfusion (0.14 mg/kg/min intravenously, during 2 minutes). Absolute CFVR was calculated as the ratio of hyperemic to basal peak diastolic flow velocities; relative CFVR was calculated as the ratio between CFVR LAD and CFVR PD. Results 23 P were enrolled (57% male, mean age 57.9 ± 13.7 years). Asymmetric septal hypertrophy was verified in 70% of P, with maximal wall thickness of 21.6 ± 4.3mm. Obstructive HCM was documented in 35% of patients. CFV was successfully measured in the LAD in all patients, but only in 70% of patients in the PD due to technical issues related to poor acoustic window and anatomical constraints. 78% of P (n = 18) presented CFVR <2, denoting microcirculatory dysfunction. Relative CFVR (LAD CFVR/ PD CFVR) was ≥1 in 43% of P. P with maximal wall thickness (MWT)>20mm presented higher CFV PD at baseline (46.5 ± 17.4 vs 32.5 ± 12.6 cm/s; p = 0.072), lower CFVR PD (1.3 ± 0.3 vs 2.5 ± 0.8; p = 0.003) and greater regional difference of microcirculation (relative CFVR 1.4 ± 0.6 vs 0.8 ± 0.3; p = 0.048). At baseline conditions, CFV LAD was higher in obstructive HCM (44.0 ± 4.8 vs 35.3 ± 10.6 cm/s; p = 0.040). P with impairment in global longitudinal strain (GLS>-18%) had higher basal CFV LAD (40.1 ± 8.6 vs 30.0 ± 12.2 cm/s; p = 0.059) and PD (44.5 ± 15.2 vs 20.0 ± 5.0 cm/s; p = 0.015) but lower CFVR PD (1.5 ± 0.5 vs 2.8 ± 1.1; p = 0.039). The reduction in CFVR PD was also noted in P with time to peak longitudinal strain dispersion >90mseg (CFVR PD 1.2 ± 0.2vs1.9 ± 0.9;p = 0.012). Conclusion Higher CFV at baseline was noted in P with greater MWT, obstructive HCM and worse GLS. Coronary microcirculatory dysfunction was associated with the degree of LV hypertrophy and impairment in LV systolic performance.
Abstract 16562: Subclinical Flow Inefficiencies in Non-Obstructive Hypertrophic Cardiomyopathy Subgroups Revealed by 4D Flow Cardiovascular Magnetic Resonance

Karin Pola,Zakariye Ashkir,Saul G Myerson,Håkan Arheden,Hugh Watkins,Stefan Neubauer,Per M Arvidsson,Betty Raman

DOI: https://doi.org/10.1161/circ.148.suppl_1.16562

IF: 37.8

2023-11-07

Circulation

Abstract:Background Patients with non-obstructive hypertrophic cardiomyopathy (nHCM) may exhibit flow inefficiencies despite normal flow profiles on transthoracic echocardiogram. We investigated whether left ventricular (LV) kinetic energy (KE) and hemodynamic forces (HDF) on 4D flow CMR are abnormal in nHCM, and examined the impact of genotype and hypertrophy phenotype on flow profiles. Methods 90 participants (70 HCM without echocardiographic outflow tract obstruction and 20 healthy controls) underwent 4D flow CMR. Patients were categorized as phenotype positive (P+) if they had LV hypertrophy (≥15mm or ≥13mm with an HCM family history), or phenotype negative (P-) referring to pre-hypertrophic pathogenic sarcomeric variant carriers. LV KE, HDF and transversal/longitudinal HDF ratio were computed from 4D flow CMR. Results P+ patients and controls were of similar age, but P- were younger. P+, P- and controls had comparable LV ejection fraction on CMR, and LV outflow tract pressure gradients and diastolic velocities on echocardiography (Table 1). Systolic KE was higher in P+ compared to controls (Table 1, Figure 1). Early diastolic KE was higher in P- than P+, reflecting younger P-, but did not differ between P+ and controls. Late diastolic KE was higher in P+ versus P- and controls. Systolic HDF ratio was higher in P+ than controls (Table 1, Figure 1). Diastolic HDF and HDF ratio were similar between P+ and controls. Conclusion Despite comparable flow velocities on echocardiography, nHCM exhibited higher systolic KE and HDF ratio, and late diastolic KE on 4D flow CMR relative to controls. Both the extent and pattern of hypertrophy are important determinants of abnormalities in KE and HDF.

cardiac & cardiovascular systems,peripheral vascular disease
Non-obstructive hypertrophic cardiomyopathy exhibit subclinical abnormalities in systolic and diastolic ventricular kinetic energy and systolic haemodynamic forces on 4D flow CMR

K Pola,Z Ashkir,H Arheden,H Watkins,S Neubauer,P M Arvidsson,B Raman

DOI: https://doi.org/10.1093/eurheartj/ehad655.217

IF: 39.3

2023-11-01

European Heart Journal

Abstract:Abstract Background Patients with non-obstructive hypertrophic cardiomyopathy (nHCM) exhibit a range of anatomical variations including septal, reverse septal, apical, and concentric hypertrophy. Cardiovascular magnetic resonance imaging (CMR) with 4D flow permits assessment of haemodynamic forces (HDF) and kinetic energy (KE) of intraventricular blood flow (1,2). These parameters may indicate subclinical flow inefficiencies which may not be detectable on routine transthoracic echocardiography (3,4). The aim of this study was therefore to investigate if left ventricular (LV) HDF and KE differ between nHCM and controls, and between subgroups of nHCM. Methods Patients with nHCM (n=71) and age- and sex-matched controls (n=20) underwent CMR at 3T (Trio, Siemens) (Table 1). Patients were categorised as phenotype positive (P+) based on presence of hypertrophy (maximum wall thickness ≥15mm, or ≥13mm with a positive family history), and as phenotype negative (P-) referring to pre-hypertrophic sarcomeric variant carriers. Patients with P+ nHCM were classified into subgroups based on the pattern of hypertrophy. Left ventricular HDF and KE were computed over the cardiac cycle using validated modules (1) (Figure 1). Measurements of HDF were based on the Navier-Stokes equations (1), and analysed in three orthogonal directions as root mean square and peak values for systole and diastole. Force ratio was calculated as the sum of the two transverse components divided by the longitudinal component. The Mann-Whitney U test was used for group comparisons, Pearson analysis for correlations, and Fisher’s exact test for binary categorical data. Results P+, P- patients and controls had comparable LV ejection fraction from CMR, LV outflow tract pressure gradients, and diastolic parameters on echocardiography (Table 1). Systolic HDF and force ratio were increased, primarily in the lateral wall-septum direction in septal and reverse septal P+ patients compared to controls, but did not differ in any other directions in P+ compared to P- patients and to controls (Table 1, Figure 1). Diastolic HDF and force ratio did not differ between groups. Systolic KE was increased in P+ patients compared to P- and to controls (Table 1, Figure 1), mainly through increased KE in patients with septal and reverse septal hypertrophy. P+ patients also had increased late diastolic (A-wave) KE relative to P- patients and to controls (Table 1). Both systolic KE and force ratio correlated with maximum wall thickness in patients (r=0.31, p=0.005; r=0.43, p<0.0001). Conclusion In non-obstructive hypertrophic cardiomyopathy, left ventricular HDF and KE analysis from 4D flow CMR detect subclinical flow abnormalities. Increased systolic HDF and KE are linked to the extent and pattern of hypertrophy. Late diastolic A-wave KE was also abnormal in P+ patients despite normal diastolic velocities on echocardiography.Table 1Figure 1

cardiac & cardiovascular systems
Apical aneurysm formation in apical hypertrophic cardiomyopathy: Pilot study with cardiac magnetic resonance

Kai Yang,Shi-Qin Yu,Xiu-Yu Chen,Yan-Yan Song,Shu-Juan Yang,Chen Cui,Kan-Kan Zhao,Meng-Die Wei,Min-Jie Lu,Shi-Hua Zhao

DOI: https://doi.org/10.1016/j.ijcard.2022.09.024

IF: 4.039

2023-01-01

International Journal of Cardiology

Abstract:BACKGROUND: The dynamic changes and apical aneurysm formation in apical hypertrophic cardiomyopathy (HCM) have not been specifically described. This study aimed to describe these changes to better understand the progression of apical HCM.METHODS AND RESULTS: Seventy-two patients with apical HCM who underwent at least two cardiac magnetic resonance (CMR) examinations were retrospectively included in this study. The mean interval between the first and last CMR examinations was 50.1 ± 26.8 months (ranging from 4 to 118 months). Compared with the initial values, the left atrial diameter, maximum left ventricular wall thickness and late gadolinium enhancement extent significantly increased (all P < 0.05), while the left ventricular ejection fraction significantly decreased (P < 0.05), at the latest CMR examination. More importantly, the dynamic process of apical aneurysm formation in apical HCM was observed in a subset of patients, which may follow these four stages: starting with systolic apical cavity obliteration, then broadening of the apical slit in systole, further developing into an apical outpouching, and finally forming an apical aneurysm. Eleven patients experienced adverse cardiovascular events, including new-onset or progressive atrial fibrillation (n = 7), hospitalization with heart failure (n = 3) and implantable cardioverter defibrillator intervention (n = 1), at the time of the latest CMR examination.CONCLUSIONS: In the progression of apical HCM, cardiac structure and function will change accordingly. Apical aneurysm formation in apical HCM is a chronic and continuous dynamic process that may follow a 4-step pathway of disease progression.

cardiac & cardiovascular systems
4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy

Pim van Ooij,Bradley D Allen,Carla Contaldi,Julio Garcia,Jeremy Collins,James Carr,Lubna Choudhury,Robert O Bonow,Alex J Barker,Michael Markl

DOI: https://doi.org/10.1002/jmri.24962

Abstract:Purpose: Hypertrophic cardiomyopathy (HCM) is associated with altered hemodynamics in the left ventricular outflow tract (LVOT) and myocardial tissue abnormalities such as fibrosis. The aim of this study was to quantify changes in LVOT 3D hemodynamics and myocardial extracellular volume fraction (ECV, measure of fibrosis) and to investigate relationships between elevated flow metrics and left ventricular (LV) tissue abnormalities. Materials and methods: Cardiac magnetic resonance imaging (MRI) including 4D flow (field strength = 1.5T, resolution = 2.1-4.0 × 2.1-4.0 × 2.5-3.2 mm(3) ; venc = 150-250 cm/s; TE/TR/FA = 2.2-2.5msec/4.6-4.9msec/15°) for the in vivo assessment of 3D blood flow velocities with full coverage of the LVOT was applied in 35 patients with HCM (54 ± 15 years) and 10 age-matched healthy controls (45 ± 14 years). In addition, pre- and postcontrast myocardial T1 -mapping (resolution = 2.3 × 1.8 mm, slice thickness = 8 mm, TE/TR-FA = 1.0-1.1msec/2.0-2.2msec/35°) of the LV (basal, mid-ventricular, apical short axis) was performed in a subgroup of 23 HCM patients. Analysis included the segmentation of the LVOT and quantification of peak systolic LVOT pressure gradients and rate of viscous energy loss EL ' as well as left ventricular ECV. Results: HCM patients demonstrated significantly elevated peak systolic LVOT pressure gradients (21 ± 16 mmHg vs. 9 ± 2 mmHg) and energy loss EL ' (3.8 ± 2.5 mW vs. 1.5 ± 0.7 mW, P < 0.005) compared to controls. There was a significant relationship between increased LV fibrosis (ECV) with both elevated pressure gradients (R(2) = 0.44, P < 0.001) and energy loss EL ' (R(2) = 0.46, P < 0.001). Conclusions: The integration of 4D-flow and T1 -mapping-MRI allowed for the evaluation of tissue and flow abnormalities in HCM patients. Our findings suggest a mechanistic link between abnormal LVOT flow, increased LV loading, and adverse myocardial remodeling in HCM.
Transapical Approach to Septal Myectomy for Hypertrophic Cardiomyopathy

Alexander Afanasyev,Alexander Bogachev-Prokophiev,Sergei Zheleznev,Mikhail Ovcharov,Anton Zalesov,Ravil Sharifulin,Igor’ Demin,Bashir Tsaroev,Vladimir Nazarov,Alexander Chernyavskiy

DOI: https://doi.org/10.3390/life14010125

2024-01-16

Life

Abstract:A 63-year-old symptomatic female with apical hypertrophic cardiomyopathy and diastolic disfunction was admitted to the hospital. What is the best way to manage this patient? This study is a literature review that was performed to answer this question. The following PubMed search strategy was used: 'Hypertrophic obstructive cardiomyopathy' [All Fields] OR 'apical myectomy' [All Fields], NOT 'animal [mh]' NOT 'human [mh]' NOT 'comment [All Fields]' OR 'editorial [All Fields]' OR 'meta-analysis [All Fields]' OR 'practice-guideline [All Fields]' OR 'review [All Fields]' OR 'pediatrics [mh]'. The natural history of the disease has a benign prognosis; however, a watchful strategy was associated with the risk of adverse cardiovacular events. Contrastingly, transapical myectomy was associated with low surgical risk and acceptable outcomes. In our case, the patient underwent transapical myectomy with an unconventional post-operative period. Control echocardiography showed marked left ventricular (LV) cavity enlargement: LV end-diastolic volume, 74 mL; LV ejection fraction, 65%; and LV stroke volume index increased to 27 mL/m2. The patient was discharged 7 days after myectomy. At 6 months post-operation, the patient was NYHA Class I, with a 6 min walk test score of 420 m. Therefore, transapical myectomy may be considered as a feasible procedure in patients with apical hypertrophic cardiomyopathy and progressive heart failure.

biology
Flow inefficiencies in non-obstructive HCM revealed by kinetic energy and hemodynamic forces on 4D-flow CMR

K Pola,Z Ashkir,S Myerson,H Arheden,H Watkins,S Neubauer,P M Arvidsson,B Raman

DOI: https://doi.org/10.1093/ehjimp/qyae074

2024-07-16

Abstract:Aims: Patients with non-obstructive hypertrophic cardiomyopathy (HCM) exhibit myocardial changes which may cause flow inefficiencies not detectable on echocardiogram. We investigated whether left ventricular (LV) kinetic energy (KE) and hemodynamic forces (HDF) on 4D-flow cardiovascular magnetic resonance (CMR) can provide more sensitive measures of flow in non-obstructive HCM. Methods and results: Ninety participants (70 with non-obstructive HCM and 20 healthy controls) underwent 4D-flow CMR. Patients were categorized as phenotype positive (P+) based on maximum wall thickness (MWT) ≥ 15 mm or ≥13 mm for familial HCM, or pre-hypertrophic sarcomeric variant carriers (P-). LV KE and HDF were computed from 4D-flow CMR. Stroke work was computed using a previously validated non-invasive method. P+ and P- patients and controls had comparable diastolic velocities and LV outflow gradients on echocardiography, LV ejection fraction, and stroke volume on CMR. P+ patients had greater stroke work than P- patients, higher systolic KE compared with controls (5.8 vs. 4.1 mJ, P = 0.0009), and higher late diastolic KE relative to P- patients and controls (2.6 vs. 1.4 vs. 1.9 mJ, P < 0.0001, respectively). MWT was associated with systolic KE (r = 0.5, P < 0.0001) and diastolic KE (r = 0.4, P = 0.005), which also correlated with stroke work. Systolic HDF ratio was increased in P+ patients compared with controls (1.0 vs. 0.8, P = 0.03) and correlated with MWT (r = 0.3, P = 0.004). Diastolic HDF was similar between groups. Sarcomeric variant status was not associated with KE or HDF. Conclusion: Despite normal flow velocities on echocardiography, patients with non-obstructive HCM exhibited greater stroke work, systolic KE and HDF ratio, and late diastolic KE relative to controls. 4D-flow CMR provides more sensitive measures of haemodynamic inefficiencies in HCM, holding promise for clinical trials of novel therapies and clinical surveillance of non-obstructive HCM.
Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis

Z Ashkir,S Johnson,A J Lewandowski,A Hess,E Wicks,M Mahmod,S Myerson,T Ebbers,H Watkins,S Neubauer,C J Carlhäll,B Raman

DOI: https://doi.org/10.1093/ehjci/jead074

2023-08-23

Abstract:Aims: Hypertrophic cardiomyopathy (HCM) is characterized by hypercontractility and diastolic dysfunction, which alter blood flow haemodynamics and are linked with increased risk of adverse clinical events. Four-dimensional flow cardiac magnetic resonance (4D-flow CMR) enables comprehensive characterization of ventricular blood flow patterns. We characterized flow component changes in non-obstructive HCM and assessed their relationship with phenotypic severity and sudden cardiac death (SCD) risk. Methods and results: Fifty-one participants (37 non-obstructive HCM and 14 matched controls) underwent 4D-flow CMR. Left-ventricular (LV) end-diastolic volume was separated into four components: direct flow (blood transiting the ventricle within one cycle), retained inflow (blood entering the ventricle and retained for one cycle), delayed ejection flow (retained ventricular blood ejected during systole), and residual volume (ventricular blood retained for >two cycles). Flow component distribution and component end-diastolic kinetic energy/mL were estimated. HCM patients demonstrated greater direct flow proportions compared with controls (47.9 ± 9% vs. 39.4 ± 6%, P = 0.002), with reduction in other components. Direct flow proportions correlated with LV mass index (r = 0.40, P = 0.004), end-diastolic volume index (r = -0.40, P = 0.017), and SCD risk (r = 0.34, P = 0.039). In contrast to controls, in HCM, stroke volume decreased with increasing direct flow proportions, indicating diminished volumetric reserve. There was no difference in component end-diastolic kinetic energy/mL. Conclusion: Non-obstructive HCM possesses a distinctive flow component distribution pattern characterised by greater direct flow proportions, and direct flow-stroke volume uncoupling indicative of diminished cardiac reserve. The correlation of direct flow proportion with phenotypic severity and SCD risk highlight its potential as a novel and sensitive haemodynamic measure of cardiovascular risk in HCM.

Erratum to: Rapid immunohistochemistry based on alternating current electric field for intraoperative diagnosis of brain tumors

Prevalence, sex differences, and implications of pulmonary hypertension in patients with apical hypertrophic cardiomyopathy

Apical Ischemia Is a Universal Feature of Apical Hypertrophic Cardiomyopathy

Electromechanical Relationship in Hypertrophic Cardiomyopathy

Determination of 1,4-Dioxane in Drinking Water by Gas Chromatography/Mass Spectrometry (GC/MS) with Selected Ion Monitoring (SIM)

Interventricular Septal Involvement Is Associated with More Impaired Ventricular Function and Mechanics in Apical Hypertrophic Cardiomyopathy

Clinical Characteristics and Outcomes in Patients With Apical and Nonapical Hypertrophic Cardiomyopathy

Clinical Course and Treatment of Patients With Apical Aneurysms Due to Hypertrophic Cardiomyopathy

[The echocardiographic diagnostic characteristics and follow-up of apical hypertrophic cardiomyopathy.].

ASSA14-04-03 the Clinical Characteristics and Coronary Angiography Features of Patients with Apical Hypertrophic Cardiomyopathy

Presence of Apical Aneurysm and Its Impact on Left Ventricular Mechanics and Mechano‐Energetic Coupling in Patients With Apical Hypertrophic Cardiomyopathy

Value of Multidetector Computed Tomography in Patients With Chest Pain and Suspected Apical Hypertrophic Cardiomyopathy

Non-invasive assessment of left ventricular hemodynamic forces in hypertrophic cardiomyopathy

P1594 Relationship between left ventricular morphology and systolic performance and coronary microcirculatory dysfunction in hypertrophic cardiomyopathy

Abstract 16562: Subclinical Flow Inefficiencies in Non-Obstructive Hypertrophic Cardiomyopathy Subgroups Revealed by 4D Flow Cardiovascular Magnetic Resonance

Non-obstructive hypertrophic cardiomyopathy exhibit subclinical abnormalities in systolic and diastolic ventricular kinetic energy and systolic haemodynamic forces on 4D flow CMR

Apical aneurysm formation in apical hypertrophic cardiomyopathy: Pilot study with cardiac magnetic resonance

4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy

Transapical Approach to Septal Myectomy for Hypertrophic Cardiomyopathy

Flow inefficiencies in non-obstructive HCM revealed by kinetic energy and hemodynamic forces on 4D-flow CMR

Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis